Chemistry:Camizestrant
From HandWiki
Camizestrant is an investigational new drug that is being evaluated to treat breast cancer.[1] It is an estrogen receptor alpha antagonist and a selective estrogen receptor degrader (SERD).[2]
References
- ↑ "Camizestrant - AstraZeneca". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800052720.
- ↑ "Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist". Journal of Medicinal Chemistry 63 (23): 14530–14559. December 2020. doi:10.1021/acs.jmedchem.0c01163. PMID 32910656.
 |  |
